The toxicity of busulphan and cyclophosphamide as the preparative regimen for bone marrow transplantation
Authors:
- 1 April 1991
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 77 (4) , 529-534
Abstract
Summary. The toxicity of the conditioning regimen of high dose busulphan (Bu) (16 mg/kg) and cyclophosphamide (Cy) (120 mg/kg) has been compared to cyclophosphamide (Cy) (120 mg/kg) and fractionated total body irradiation (TBI) 12-14 Gy. Since 1985, 67 patients have received conditioning of Bu and Cy for HLA-identical sibling bone marrow transplants. 166 patients have received Cy and TBI since 1981. Veno-occlusive disease of the liver occurred in 19% in the Bu-Cy group and was fatal in 1/12 cases, but only in 1·3% of Cy-TBI group (PP=0·008). A multiple logistic regression analysis demonstrated the preparative regimen as the only significant risk factor for the development of veno-occlusive disease or haemorrhagic cystitis. Interstitial pneumonia was diagnosed in 12/56 evaluable patients (21%) in the Bu-Cy group and was fatal in 75%. It occurred in 39/1 37 evaluable patients (28%) in the Cy-TBI group with a 54% case mortality. Within the Bu-Cy group, the incidence of veno-occlusive disease and haemorrhagic cystitis was similar in chronic myeloid leukaemia (CML) and acute leukaemia (AL) groups, but there was a significant (P=0·003) incidence of interstitial pneumonia in the CML group 36% as compared to 7% in the AL group. Preparative regimen and age were significant risk factors in the development of interstitial pneumonia in patients with CML. A flexural and acral rash ranging from pigmentation to severe erosion was noted in the Bu-Cy group, but not in the Cy-TBI group. Thus, veno-occlusive disease, haemorrhagic cystitis and cutaneous changes were more common in patients receiving Bu-Cy. Interstitial pneumonia was more common in patients receiving Bu-Cy for CML than for AL.Keywords
This publication has 17 references indexed in Scilit:
- A COMPARATIVE STUDY OF T-CELL DEPLETED AND NON-DEPLETED MARROW TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCYAustralian and New Zealand Journal of Medicine, 1987
- Hepatic veno-occlusive diseaseThe American Journal of Medicine, 1986
- Association of BK Viruria with Hemorrhagic Cystitis in Recipients of Bone Marrow TransplantsNew England Journal of Medicine, 1986
- Acute and delayed toxicities of total body irradiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1983
- Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and CyclophosphamideNew England Journal of Medicine, 1983
- Nonbacterial Pneumonia After Allogeneic Marrow Transplantation: A Review of Ten Years' ExperienceClinical Infectious Diseases, 1982
- Busulfan-induced hemorrhagic cystitisUrology, 1981
- Acute hemorrhagic cystitis of childhood and papovavirus-like particlesThe Journal of Pediatrics, 1976
- A Review of Adenoviruses in the Etiology of Acute Hemorrhagic CystitisJournal of Urology, 1976
- Urological Complications of CyclophosphamideBritish Journal of Urology, 1973